ArcherDX launches B Cell Receptor sequencing assays for immune repertoire characterization

ArcherDX launches B Cell Receptor sequencing assays for immune repertoire characterization

BOULDER -- ArcherDX , a leader in NGS-based fusion assays, today announced the release of Archer Immunoverse B Cell Receptor (BCR) assays to characterize the human B cell repertoire. The... Read More

Wednesday May 17, 2017 0 comments Tags: Boulder, ArcherDx, Jason Myers, Brian Kudlow